Delivery Order SPE2DB20D7066-SPE2DB25FC4GM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,744.20 to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18-count) on September 11, 2025, with completion targeted for September 12, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single-line pharmaceutical product delivery under the...
- The Defense Logistics Agency awarded a delivery order valued at $1,029.95 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Chloraseptic Sore Throat Lozenges (18-count package). This competitively awarded, firm fixed-price delivery order is non-set-aside and carries an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,111.64, is for the supply of 4,567,926,337 units of Chloraseptic sore throat lozenges. The contract has an ultimate completion date of April 16, 2025 and was awarded on April 15, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $5,290.15 delivery order to AmerisourceBergen Drug Corp for Chloraseptic Max 15-10 mg lozenges (15 count) on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of the vendor's critical role in supplying...
- The Defense Logistics Agency awarded a $314,790 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 18-count packages of Chloraseptic sore throat lozenges. As part of DLA's medical supply chain support to the Department of Defense, this contract will provide sore throat relief medications to military treatment facilities from the contractor's distribution center in Conshohocken, Pennsylvania. Amerisourcebergen will fulfill the requirements as the prime contractor under this...
- The Defense Logistics Agency awarded a $802.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 18 count bottles of Chloraseptic sore throat lozenges. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order period of performance is July 31, 2023 through August 1, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill this order to supply sore throat remedies for DLA's stockpile of...
- The Defense Logistics Agency awarded a $145 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 18 count packages of Chloraseptic sore throat lozenges. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order runs from July 10th through July 11th, 2023 under the parent company Amerisourcebergen Corporation's indefinite delivery vehicle with DLA. As a leading provider of pharmaceuticals and medical supplies,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,358.92 firm fixed price delivery order is for the supply of Chloraseptic Sore Throat Lozenges, with a period of performance through January 2025. The award is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This firm fixed-price delivery order, valued at $162, was awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corporation for the supply of 18 count packages of Chloraseptic sore throat lozenges. Place of performance will be Amerisourcebergen's facilities in Conshohocken, Pennsylvania, with delivery required between July 10-11, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the U.S. Armed Forces through procurement...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $2,403.02 firm-fixed-price contract is for the supply of Chloraseptic Sore Throat Lozenges. It has a completion date of September 13, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of medical...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4GMDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,119.84 for Chloraseptic sore throat lozenges (18-count). This firm fixed-price contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a routine pharmaceutical supply delivery under the company's broader federal medical procurement relationship. The order will be performed in Conshohocken, Pennsylvania, the headquarters location of AmerisourceBergen Drug Corp, and no set-aside designation was applied to this competitive award. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. That prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support contract enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs and other federal medical systems worldwide. The company's federal contract portfolio demonstrates its established capability as a major pharmaceutical distributor supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities through flexible and competitively awarded contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/7/25 |